During advanced carcinogenesis stages, TGF-β promotes OSCC invasion and metastasis, acting by many pathways, including suppression of immune surveillance, induction of the epithelial-mesenchymal transition (EMT), and modulation of the tumor microenvironment to promote carcinoma-cell proliferation. The gene discussed is TGFB1; the disease is carcinoma.